D2M Biotherapeutics is a startup biotech company located at Natick, MA. D2M (Data to Medicine) is a human-genetics driven biotherapeutics discovery company with a focus on immuno-oncology and inflammatory diseases. D2M has built up a platform of novel target discovery via deep mining the unprecedented disease genomic data. D2M is building up a sharply focused pipeline of monoclonal antibody or protein therapeutics targeting human genetics validated immune pathways. D2M's immediate focus is creating novel classes of biologics on cancers beyond anti-PD1/L1 IO therapies and rare immunology diseases currently with limited therapeutic options.
Company Details
- Employees
- 10
- Address
- 22 Strathmore Rd, Natick,massachusetts 01760,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- biotechnology, immunology, human genetics, immunology-oncology, inflammatory disease, antibody discovery.
- HQ
- Natick, Massachusetts
D2m Biotherapeutics Questions
D2M Biotherapeutics's LinkedIn profile is https://www.linkedin.com/company/d2mbio
D2M Biotherapeutics has
10 employees.
View email and phone details for 10
employees at D2M Biotherapeutics.
D2M Biotherapeutics's industry is
Biotechnology Research
D2M Biotherapeutics's top competitors are
Gentibio,
Gv20 Therapeutics,
Massachusetts Eye And Ear,
Initium Therapeutics Inc,
Abi-Lab,
Nimbus Therapeutics,
Gsk,
Nona Biosciences,
Novasenta,
Allorion Therapeutics.
D2M Biotherapeutics's categories are Biotechnology Research
